IMAC Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement
November 30 2020 - 4:05PM
IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), a
provider of innovative medical advancements and care specializing
in regenerative rehabilitation orthopedic treatments without the
use of surgery or opioids, today announces that it has received a
letter from The Nasdaq Stock Market LLC ("Nasdaq") that IMAC has
regained compliance with Nasdaq's minimum bid price for continued
listing on the Nasdaq Capital Market set forth in Nasdaq Listing
Rule 5550(a)(2).
As previously reported, the Company was not in
compliance with the minimum bid price requirement because the
closing bid price for its common stock was less than $1.00 for the
30 consecutive business days preceding October 13, 2020. That
matter is now closed.
About IMAC Holdings, Inc.
IMAC Holdings was created in March 2015 to
expand on the footprint of the original IMAC Regeneration Center,
which opened in Kentucky in August 2000. IMAC Regeneration Centers
combine life science advancements with traditional medical care for
movement restricting diseases and conditions. IMAC owns or manages
15 outpatient clinics that provide regenerative, orthopedic and
minimally invasive procedures and therapies. It has partnered with
several active and former professional athletes, opening six Ozzie
Smith IMAC Regeneration Centers, two David Price IMAC Regeneration
Centers, as well as Mike Ditka IMAC Regeneration Centers and a Tony
Delk IMAC Regeneration Center. IMAC’s outpatient medical clinics
emphasize its focus around treating sports and orthopedic injuries
and movement-restricting diseases without surgery or opioids. More
information about IMAC Holdings, Inc. is available at
www.imacregeneration.com.
IMAC Press Contact: Laura Fristoelfristoe@imacrc.com
Investor Relations: Bret Shapiro(516)
222-2560brets@coreir.com
IMAC (NASDAQ:IMAC)
Historical Stock Chart
From Mar 2024 to Apr 2024
IMAC (NASDAQ:IMAC)
Historical Stock Chart
From Apr 2023 to Apr 2024